Clinical Trials Browser

Phase 2 × Unknown × atezolizumab × Clear all

NCT04739670 2024-03-01

BELLA

Phase 2 Unknown

Recurrence, Triple Negative Breast Neoplasms

NCT05266937 2024-02-01

Atezolizumab Plus CArboplatin Plus Nab-paclitaxel

Phase 2 Unknown

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05833126 2023-12-15

Hepatic Arterial Infusion Chemotherapy in Combination With Atezolizumab and Bevacizumab for Second-line Treatment of Patients With Recurrent Liver Cancer After Liver Transplantation

Phase 2 Unknown

Recurrent Liver Cancer After Liver Transplantation

NCT04591431 2023-10-03

ROME

Phase 2 Unknown

BreastGastrointestinalThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms

NCT03818061 2023-09-28

ATHENA

Phase 2 Unknown

Head and Neck Neoplasms

NCT04659382 2023-08-18

SIRTCI

Phase 2 Unknown

Gastrointestinal

Colorectal Neoplasms

NCT03961698 2023-08-14

MARIO-3

Phase 2 Unknown

BreastGenitourinary

Breast Neoplasms, Carcinoma, Renal Cell, Triple Negative Breast Neoplasms

NCT03363867 2023-08-07

BEACON

Phase 2 Unknown

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT05886465 2023-06-02

HAIC Plus A+T for Patients With High-risk HCC: a Single-arm Phase 2 Trial

Phase 2 Unknown

Gastrointestinal

Carcinoma, Hepatocellular

NCT03654833 2023-03-14

MiST

Phase 2 Unknown

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT05429866 2023-03-08

Immunological Variables Associated to ICI Toxicity in Cancer Patients

Phase 2 Unknown

BreastDermatologicGastrointestinalGenitourinaryHead & NeckOther solid neoplasmThoracic

Mesothelioma, Malignant, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Melanoma, Carcinoma, Merkel Cell, Small Cell Lung Carcinoma

NCT05038657 2022-10-03

AURORA

Phase 2 Unknown

Carcinoma, Squamous Cell, Urologic Neoplasms

NCT05396937 2022-05-31

Efficacy and Safety of T+A+RAD in HCC

Phase 2 Unknown

Gastrointestinal

Carcinoma, Hepatocellular

NCT03262454 2022-04-06

Atezolizumab

Phase 2 Unknown

Small Cell Lung Cancer Recurrent

NCT05034055 2021-09-05

SKYROCKET

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT04739202 2021-03-29

IMMUNOGAST

Phase 2 Unknown

Gastrointestinal

Adenocarcinoma, Stomach Neoplasms

NCT04696939 2021-01-06

Combined Atezolizumab and Chemotherapy (Carboplatin Plus Etoposide) in Neoadjuvant Treating Limited-Stage Small Cell Lung Cancer Patients

Phase 2 Unknown

Small Cell Lung Carcinoma

NCT03544723 2020-06-09

Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.

Phase 2 Unknown

BreastDermatologicGastrointestinalGenitourinaryGynecologicLymphoidThoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Hodgkin Disease, Liver Neoplasms, Lymphoma, Melanoma, Stomach Neoplasms, Carcinoma, Merkel Cell, Neoplasms, Squamous Cell, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT03647956 2019-04-17

Atezolizumab in Combination With Bevacizumab, Carboplatin and Pemetrexed for EGFR-mutant Metastatic NSCLC Patients After Failure of EGFR Tyrosine Kinase Inhibitors

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT03620435 2018-08-13

Trimodal Therapy Plus Atezolizumab in Muscle-invasive Bladder Cancer

Phase 2 Unknown

Safety Issues

NCT03616691 2018-08-06

Atezolizumab Monotherapy and Consequent Therapy With Atezolizumab Plus Bevacizumab for NSCLC

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung